The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.80
Bid: 76.80
Ask: 80.60
Change: -2.55 (-3.21%)
Spread: 3.80 (4.948%)
Open: 77.80
High: 78.10
Low: 76.80
Prev. Close: 79.35
KYGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kerry to acquire Lactase Enzymes Business

12 Dec 2023 16:13

RNS Number : 5363W
Kerry Group PLC
12 December 2023

12 December 2023

LEI: 635400TLVVBNXLFHWC59

KERRY GROUP

Kerry to acquire Lactase Enzymes Business

Kerry Group plc ("Kerry"), the global taste & nutrition company, announces it has entered into a definitive agreement to acquire part of the global lactase enzyme business of Chr. Hansen Holding A/S ("Chr. Hansen") and Novozymes A/S ("Novozymes") (together the "Lactase Enzymes Business") on a carve out basis¹. This acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger approval process.

The Lactase Enzymes Business which includes NOLA® Products, further enhances Kerry's biotechnology solutions capability following the acquisitions of c-LEcta and Enmex². This acquisition adds enzyme technology which helps create lactose-free and sugar reduced dairy products, while preserving their authentic clean taste. Global demand for lactase is being driven by increased awareness of lactose intolerance, while many consumers are also choosing lactose-free for lifestyle and health reasons.

The Lactase Enzymes Business had attributable revenue of approximately ?40m in 2022 with sales in over 50 countries. Total consideration is ?150m subject to routine closing adjustments, with the acquisition expected to close in the first half of 2024.

¹ Acquisition comprises certain trade and assets of Chr. Hansen's global lactase enzyme business and 100% of the share capital of Nuocheng Trillion Food (Tianjin) Co., Ltd, a Chinese subsidiary of Novozymes.

² Acquisition of c-LEcta GmbH completed in March 2022 and Enmex S.A. de C.V. in December 2021.

ENDS

About Kerry

Kerry is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. We innovate with our customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Our leading consumer insights, global RD&A team of 1,100+ food scientists and extensive global footprint enable us to solve our customers' complex challenges with differentiated solutions. At Kerry, we are driven to be our customers' most valued partner, creating a world of sustainable nutrition, and to reach over 2 billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com.

CONTACT INFORMATION

Investor Relations

Marguerite Larkin, Chief Financial Officer

+353 66 7182292 | investorrelations@kerry.ie

William Lynch, Head of Investor Relations

+353 66 7182292 | investorrelations@kerry.ie

Media

Catherine Keogh, Chief Corporate Affairs & Brand Officer

+353 45 930188 | corpaffairs@kerry.com

Website

www.kerry.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACQBLBDDDBBDGXD
Date   Source Headline
1st Oct 20155:20 pmRNSReplacement Voting Rights and Share Capital
1st Oct 201512:34 pmRNSOpening of Global Technology & Innovation Centre
29th Sep 20153:07 pmRNSKerry Group Announces Board Appointment
3rd Sep 20158:41 amRNSKerry Group - Pre-Stabilisation Notice
1st Sep 201512:08 pmRNSVoting Rights and Share Capital
6th Aug 20157:00 amRNSInterim Management Report
4th Aug 201512:17 pmRNSVoting Rights and Share Capital
23rd Jul 201511:01 amRNSTR-1: Notification
6th Jul 20159:29 amRNSBlocklisting 6 Monthly Return
1st Jul 201512:12 pmRNSVoting Rights and Share Capital
2nd Jun 20152:28 pmRNSVoting Rights and Share Capital
1st May 201512:53 pmRNSVoting Rights and Share Capital
1st May 201510:24 amRNSKerry Group plc Result of AGM
30th Apr 201511:40 amRNSKerry Group: Q1 2015 Interim Management Statement
2nd Apr 201511:36 amRNSAnnual Report and AGM Notice
2nd Apr 201510:26 amRNSVoting Rights and Share Capital
31st Mar 201510:17 amRNSBlocklisting Six Monthly Return
24th Mar 20154:49 pmRNSDirector/PDMR Shareholding
24th Mar 20154:47 pmRNSDirector/PDMR Shareholding
24th Mar 20154:47 pmRNSDirector/PDMR Shareholding
24th Mar 20154:46 pmRNSDirector/PDMR Shareholding
24th Mar 20154:45 pmRNSDirector/PDMR Shareholding
11th Mar 201510:29 amRNSDirector/PDMR Shareholding
2nd Mar 20152:31 pmRNSVoting Rights and Share Capital
25th Feb 201511:40 amRNSDirector/PDMR Shareholding
24th Feb 20157:00 amRNSPreliminary Statement of Results
2nd Feb 201511:12 amRNSVoting Rights and Share Capital
5th Jan 201511:44 amRNSVoting Rights and Share Capital
1st Dec 201412:53 pmRNSVoting Rights and Share Capital
6th Nov 201411:35 amRNSQ3 Interim Management Statement
4th Nov 20144:16 pmRNSVoting Rights and Share Capital
3rd Oct 20143:40 pmRNSVoting Rights and Share Capital
1st Oct 20142:22 pmRNSDirectorate Changes
1st Sep 201412:37 pmRNSVoting Rights and Share Capital
7th Aug 20147:00 amRNSInterim Management Report
1st Aug 20145:35 pmRNSBlock Listing Six Monthly Return
1st Aug 201412:22 pmRNSVoting Rights and Share Capital
1st Jul 201411:25 amRNSVoting Rights and Share Capital
3rd Jun 20142:57 pmRNSVoting Rights and Share Capital
15th May 20144:01 pmRNSKerry Opens New RD&A Centre in Durban South Africa
2nd May 20149:37 amRNSResult of AGM
1st May 201412:37 pmRNSVoting Rights and Share Capital
1st May 201411:30 amRNSInterim Management Statement: Kerry Group AGM
4th Apr 201410:17 amRNSKerry Group plc Annual Report and AGM Notice
27th Mar 20142:15 pmRNSDirector/PDMR Shareholding
13th Mar 20142:39 pmRNSDirector/PDMR Shareholding
4th Mar 20149:53 amRNSVoting Rights and Share Capital
25th Feb 20147:00 amRNSPreliminary Statement of Results
3rd Feb 20145:19 pmRNSVoting Rights and Share Capital
6th Jan 20143:37 pmRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.